心血管药物临床应用指导原则VIP免费

心血管药物临床应用指导原则（征求意见稿）目录前言............................................................................5第一章心血管药物临床应用的基本原则.............................................6一、严格掌握心血管药物治疗的适应证.............................................6二、合理制订心血管药物治疗方案.................................................6三、加强疾病管理，提高患者依从性...............................................7四、重视疾病的综合治疗.........................................................7五、监测心血管药的不良反应.....................................................8第二章心血管药物临床应用的管理.................................................9一、管理要求..................................................................10二、落实与督查................................................................11第三章各类心血管药物的适应证、禁忌证和注意事项................................12一、血管紧张素转换酶抑制剂....................................................12二、血管紧张素Ⅱ受体拮抗剂（ARB）.............................................14三、钙离子拮抗剂..............................................................15（一）二氢吡啶类............................................................15（二）非二氢吡啶类..........................................................16（三）钙拮抗剂注射液........................................................17四、Β受体阻滞剂..............................................................17五、Α受体阻滞剂..............................................................19六、调脂药....................................................................19（一）他汀类................................................................19（二）贝特类................................................................21（三）烟酸..................................................................22（四）树脂类................................................................23七、血管扩张剂................................................................23（一）肼苯达嗪..............................................................24（二）硝普钠................................................................24八、硝酸酯类药物..............................................................25九、洋地黄类药物..............................................................28十、强心双吡啶类正性肌力药物..................................................29十一、拟交感胺类正性变力性药物................................................30（一）噻嗪类利尿剂..........................................................32（二）襻利尿剂..............................................................33（三）保钾利尿剂............................................................34十三、抗血小板药物............................................................35（一）阿司匹林..............................................................35（二）氯吡格雷..............................................................37（三）血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂........................................37十四、抗凝药物................................................................39（一）普通肝素..............................................................39（二）低分子肝素............................................................41（三）华法林...............................